Here's Why You Should Hold Nordson Stock in Your Portfolio

Group 1: Company Performance and Growth - Nordson Corporation (NDSN) is experiencing solid momentum in the Industrial Precision Solutions segment, driven by the popularity of its packaging and nonwoven product lines [1] - The company expects sales for fiscal 2024 to be in the range of $2.665-$2.705 billion, indicating a year-over-year growth of 2.1% at the midpoint [1] - The acquisition of Atrion Corporation in August 2024 will enhance NDSN's medical offerings in infusion and cardiovascular therapies [2] - The ARAG Group acquisition in August 2023 has expanded NDSN's capabilities in precision dispensing technology, contributing to a 4% revenue boost in the third quarter of fiscal 2024 [3] Group 2: Shareholder Returns - NDSN is committed to rewarding shareholders, having paid out dividends of $116.8 million in the first nine months of fiscal 2024, a 4.8% increase year over year [4] - The company repurchased shares worth $34.1 million during the same period and increased its dividend by 15% to 78 cents per share in August 2024, marking the 61st consecutive year of dividend increases [4] Group 3: Market Challenges - The Advanced Technology Solutions segment is facing challenges due to lower demand for electronics processing and x-ray and test product lines [6] - The Medical and Fluid Solutions segment is also experiencing soft demand for interventional solutions and fluid components [6] - Rising costs and expenses are a concern, with cost of sales increasing by 1.5% year over year and selling and administrative expenses rising by 2.4% in the fiscal third quarter [7]